These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 546349)

  • 21. The influence of host factors on drug response. VII. Implications for interpretation of clinical trials and other published studies on drug response in man.
    Vesell ES
    Ration Drug Ther; 1981 Dec; 15(12):1-5. PubMed ID: 7339701
    [No Abstract]   [Full Text] [Related]  

  • 22. Early clinical drug evaluation units reports.
    Psychopharmacol Bull; 1971 Jul; 7(3):65-92. PubMed ID: 4940649
    [No Abstract]   [Full Text] [Related]  

  • 23. Drug interactions we all overlook. Start with the medicine cabinet.
    Messner RL; Gardner SS
    RN; 1993 Jan; 56(1):50-3. PubMed ID: 8451583
    [No Abstract]   [Full Text] [Related]  

  • 24. [Polychemotherapy and the prevention of drug incompatibility].
    Gogin EE
    Klin Med (Mosk); 1991 Aug; 69(8):3-6. PubMed ID: 1791704
    [No Abstract]   [Full Text] [Related]  

  • 25. Interpretation of studies on adverse drug reactions.
    Miller RR
    Am J Hosp Pharm; 1977 Jul; 34(7):753-4. PubMed ID: 888839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantitative evaluation of the exercise test].
    De Servi S
    G Ital Cardiol; 1985 Nov; 15(11):1030-1. PubMed ID: 3830753
    [No Abstract]   [Full Text] [Related]  

  • 27. Mechanisms of adverse drug reactions and interactions in veterinary medicine.
    Eckhoff GA
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1131-3. PubMed ID: 7216887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
    Becker RC
    J Thromb Thrombolysis; 2008 Jun; 25(3):300-2. PubMed ID: 18470653
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug prescribing for the elderly.
    Everitt DE; Avorn J
    Arch Intern Med; 1986 Dec; 146(12):2393-6. PubMed ID: 3778076
    [No Abstract]   [Full Text] [Related]  

  • 30. Estimating the impact of the discontinuation of medical interventions on health outcomes.
    Weiss NS
    Am J Epidemiol; 2009 Mar; 169(6):653-6. PubMed ID: 19126592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Herbal therapy: a review of potential health risks and medicinal interactions.
    Magee KA
    Orthod Craniofac Res; 2005 May; 8(2):60-74. PubMed ID: 15888118
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical biostatistics. XLV. The purposes and functions of criteria.
    Feinstein AR
    Clin Pharmacol Ther; 1978 Oct; 24(4):779-92. PubMed ID: 688738
    [No Abstract]   [Full Text] [Related]  

  • 33. Advancing economic evaluations of drug therapy.
    Navarro RP
    Med Interface; 1996 Jul; 9(7):86-7, 92. PubMed ID: 10159281
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug reactions and interactions].
    D'Arcy PF
    J Pharm Belg; 1987; 42(2):152-9. PubMed ID: 3612480
    [No Abstract]   [Full Text] [Related]  

  • 35. [Evaluation of rare side effects].
    Bruinsma W
    Ned Tijdschr Geneeskd; 1972 Sep; 116(38):1703-4. PubMed ID: 5069859
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial: Drug interactions.
    Mukerjee AB
    J Indian Med Assoc; 1975 Oct; 65(7):210-1. PubMed ID: 1214086
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the epidemiology of adverse drug reactions. VI. Utilization and interactions of prescription and nonprescription drugs in outpatients.
    Stewart RB; Cluff LE
    Johns Hopkins Med J; 1971 Dec; 129(6):319-31. PubMed ID: 5133378
    [No Abstract]   [Full Text] [Related]  

  • 38. Adverse drug event reporting. Improving the low US reporting rates.
    Edlavitch SA
    Arch Intern Med; 1988 Jul; 148(7):1499-503. PubMed ID: 3382293
    [No Abstract]   [Full Text] [Related]  

  • 39. [Surveillance of drug therapy in the hospital].
    Kewitz H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1487-502. PubMed ID: 611874
    [No Abstract]   [Full Text] [Related]  

  • 40. The Canadian drug adverse reaction reporting program.
    Napke E
    Drug Inf J; 1975; 9(2-3):224-32. PubMed ID: 10236976
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.